Literature DB >> 8396042

DIDS (4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid) inhibits an early step of protein translocation across the mammalian ER membrane.

B Jungnickel1, T A Rapoport.   

Abstract

Protein translocation across the endoplasmic reticulum (ER) membrane of yeast can be inhibited by agents believed to specifically affect the transport of ATP through the membrane (Mayinger, P. and Meyer, D.I. (1993) EMBO J. 12, 659-666), suggesting the involvement of a translocation component in the lumen of the ER that binds ATP. We demonstrate that one of the inhibitors, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), also affects the translocation of proteins into mammalian microsomes. Translocation is blocked at the point of transfer of the nascent chain from the signal recognition particle (SRP) into the ER-membrane. We also confirm that photoaffinity-labelling of microsomes with 8-azido-ATP inhibits the same early step of protein translocation. Since this step is reported to not require ATP, these results raise the possibility that, in both cases, factor(s) other than ATP-binding components of the translocation machinery are perturbed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396042     DOI: 10.1016/0014-5793(93)80235-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Binding of signal recognition particle gives ribosome/nascent chain complexes a competitive advantage in endoplasmic reticulum membrane interaction.

Authors:  A Neuhof; M M Rolls; B Jungnickel; K U Kalies; T A Rapoport
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

2.  DIDS (4,4-diisothiocyanatostilbenedisulphonic acid) induces apoptotic cell death in a hippocampal neuronal cell line and is not neuroprotective against ischemic stress.

Authors:  Matthew E Pamenter; Guy A Perkins; Xiang Q Gu; Mark H Ellisman; Gabriel G Haddad
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

3.  Isothiocyanatostilbenes as novel c-Met inhibitors.

Authors:  Alana L Gray; David T Coleman; Reneau F Castore; Mohamed M Mohyeldin; Khalid A El Sayed; James A Cardelli
Journal:  Oncotarget       Date:  2015-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.